Prediction of Lung Cancer Metastasis Risk Based on Single‐Cell Metabolic Profiling of Circulating Tumor Cells
Advanced Science · 2025-10 · 12 (39)
DOI: 10.1002/advs.202508878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 18.07.2025. Verfasst von Yang Xu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Cancer Translational Medicine Research Center, The Second Affiliated Hospital of Dalian Medical University, Dalia…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Lung Neoplasms, Single-Cell Analysis, Metabolomics. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical and Industry Joint Innovation Programs, Second Affiliated Hospital of Dalian Medical University and DICP, Liaoning Revitalization Talents Program.
Abstract (Originalsprache)
Lung cancer metastasis is a leading cause of cancer‐related mortality, necessitating innovative approaches for early prediction and personalized clinical management. A novel strategy is present to predict lung cancer metastasis risk by combining single‐cell metabolic profiling of circulating tumor cells (CTCs) with a self‐developed CTC sorting and capture platform, enabling high‐efficiency, high‐viability CTC isolation from blood. Using nanoelectrospray ionization‐atmospheric pressure chemical ionization mass spectrometry, single‐cell metabolomic profiling on 301 CTCs derived from patients and animal models are performed. 390 unique metabolites are identified and discovered distinct metabolic signatures associated with different metastatic potentials (brain and bone). Based on these metabolic profiles, a classification model that categorizes CTCs into subgroups with distinct metastatic risks are constructed. The model outperformed traditional clinical indicators and total CTC counts, achieving AUCs of 0.74 (brain metastasis) and 0.92 (bone metastasis). Prospective validation confirmed its metabolite‐based classification accuracy for one‐year metastasis risk prediction. This study highlights the potential of single‐cell metabolomics to uncover novel therapeutic targets and prognostic markers, advancing liquid biopsy from quantitative counting to qualitative analysis. The approach represents a significant advancement in precision medicine for lung cancer management, offering a personalized strategy for predicting metastasis risk and guiding clinical treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Cancer Translational Medicine Research Center, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, 116023, P. R. China.
- State Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS), University of Chinese Academy of Sciences, Liaoning Province Key Laboratory of Metabolomics, Dalian, L…
- Cancer Translational Medicine Research Center, The Second Affiliated Hospital of Dalian Medical University, Medical College of Tarim University, Xinjiang Uygur Autonomous Region, Aral, 843300, P. R. China.
- School of Integrated Circuits, Peking University, Beijing, 100871, P. R. China.
Förderung
- Medical and Industry Joint Innovation Programs
- Second Affiliated Hospital of Dalian Medical University and DICP
- Liaoning Revitalization Talents Program
- Department of Science & Technology of Liaoning Province
- Dalian Institute of Chemical Physics, Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Xu, Y., Hu, X., Yuan, Y., Liu, W., Wang, J., Yang, C., Shi, X., Qin, W., Wen, L., Lin, M., Jin, Y., Wang, W., Hu, C., Xu, G., & Wang, Q. (2025). Prediction of Lung Cancer Metastasis Risk Based on Single‐Cell Metabolic Profiling of Circulating Tumor Cells. Advanced Science, 12(39). https://doi.org/10.1002/advs.202508878
Vancouver
Xu Y, Hu X, Yuan Y, Liu W, Wang J, Yang C, et al. Prediction of Lung Cancer Metastasis Risk Based on Single‐Cell Metabolic Profiling of Circulating Tumor Cells. Advanced Science. 2025;12(39). doi:10.1002/advs.202508878
BibTeX
@article{Xu2025,
author = {Xu, Yang and Hu, Xuesen and Yuan, Yuan and Liu, Wenwen and Wang, Jian and Yang, Chunhui and Shi, Xianzhe and Qin, Wangshu and Wen, Liliang and Lin, Manqing and Jin, Yinuo and Wang, Wei and Hu, Chunxiu and Xu, Guowang and Wang, Qi},
title = {Prediction of Lung Cancer Metastasis Risk Based on Single‐Cell Metabolic Profiling of Circulating Tumor Cells},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {39},
doi = {10.1002/advs.202508878}
}
EUVIMED